Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Shares Issued (2019 - 2025)

Cyclerion Therapeutics has reported Shares Issued over the past 6 years, most recently at $1.8 million for Q3 2025.

  • Quarterly results put Shares Issued at $1.8 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $3.2 million (changed N/A YoY), and the annual figure for FY2023 was $5.0 million, changed.
  • Shares Issued for Q3 2025 was $1.8 million at Cyclerion Therapeutics, up from $1.4 million in the prior quarter.
  • Over the last five years, Shares Issued for CYCN hit a ceiling of $30.5 million in Q2 2021 and a floor of -$30.3 million in Q3 2021.
  • Median Shares Issued over the past 4 years was $1.6 million (2025), compared with a mean of $2.6 million.
  • Peak annual rise in Shares Issued hit 19685.71% in 2021, while the deepest fall reached 225.75% in 2021.
  • Cyclerion Therapeutics' Shares Issued stood at $12.5 million in 2021, then tumbled by 99.86% to $17000.0 in 2022, then surged by 29170.59% to $5.0 million in 2023, then plummeted by 63.83% to $1.8 million in 2025.
  • The last three reported values for Shares Issued were $1.8 million (Q3 2025), $1.4 million (Q1 2025), and $5.0 million (Q3 2023) per Business Quant data.